ACTIVE PHARMA AS: årsregnskap 2021 vs 2020
Grew 368% on revenue, returned to profit, cash halved-plus
approved 2022-06-30; registry 2022-07-27; journal 2022 794260
Summary
What changed
Comparing Årsregnskap 2021 with 2020 for ACTIVE PHARMA AS. Revenue 321.7k NOK → 1.51m NOK (+368.2%). Net result -267.0k NOK → +464.0k NOK. Equity -841.0k NOK → -377.0k NOK.
On the constructive side: revenue rose; operating result improved; turned profitable. Pressures included: cash fell.
Also worth watching: thin equity buffer; payroll increased; cogs fell. All figures are taken from the published annual accounts for ACTIVE PHARMA AS.
At a glance
Scorecard
What improved
-
↑
Revenue rose
Operating income / revenue moved from 321.7k NOK to 1.51m NOK (+368.2% YoY). Calculated
-
↑
Operating result improved
Operating result -204.0k NOK → +507.7k NOK (op. margin -63.4% → 33.7%). Calculated
-
↑
Turned profitable
Net result flipped from a loss of 267.0k NOK to a profit of 464.0k NOK. Calculated
-
↑
Equity strengthened
Book equity -841.0k NOK → -377.0k NOK (equity ratio -151.6% → -173.5%). Calculated
What deteriorated
-
↓
Cash fell
Bank deposits 228.9k NOK → 92.4k NOK (-59.6% YoY). Calculated
Things to notice
-
·
Thin equity buffer
Equity ratio is -173.5% of assets — limited loss-absorbing capacity on a stand-alone basis. Interpretation
-
·
Payroll increased
Salary cost 6 679 NOK → 625.5k NOK (2% → 42% of revenue). Calculated
-
·
COGS fell
COGS / varekostnad 388.5k NOK → 106.0k NOK (-72.7% YoY). Calculated